Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabis company, announced today that Spinach STIX ®, its latest innovation in its popular line-up of Spinach ® pre-rolls ...

Cronos Group stock reacts to U.S. marijuana rescheduling move The U.S. Department of Justice’s decision to reschedule certain marijuana products from Schedule I to Schedule III has put fresh attention ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

For its second quarter, Cronos -- which reports in U.S. dollars -- took in nearly $27.8 million in revenue, a figure almost 50% higher than the $19 million it earned in the same period of 2023. On a ...

Shares of Cronos Group (NASDAQ: CRON) were sinking 4.1% lower as of 10:57 a.m. ET on Tuesday and fell as much as 5.7% earlier in the day. The decline came after the U.S. Drug Enforcement ...

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2026 Annual Meeting of Shareholders on Thursday, June 18, 2026, at 11:00 a.m. ET. Cronos will be conducting the ...

Cronos Group (NASDAQ: CRON) stock jumped 9.4% through 11:30 a.m. ET Tuesday after beating Wall Street forecasts for Q3 earnings this morning. Heading into the report, analysts expected Cronos to do ...

TORONTO, June 20, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, announced an expansion of Cronos Growing Company (“GrowCo”).

Cronos Group Inc (NASDAQ:CRON) shares are trading lower by 2.78% to $2.63 during Tuesday’s session. Shares of cannabis stocks are trading lower in sympathy with Tilray, which fell after reporting ...

Cronos Group boasts a strong net cash position nearly equal to its market cap, offering downside protection and operational flexibility. Leading brands like Spinach and Lord Jones have secured top ...

TORONTO, March 16, 2026 (GLOBE NEWSWIRE)-- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, ...

TORONTO, May 08, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), today announced its 2025 first quarter business results. "2025 is shaping up to be a ...